Physician profile
Patrick Ryan Mcgrew
NPI 1710203518
$5,151.96
in general payments reported to CMS, 2019-2025
9 companies · $27.81 in 2025
The $27.81 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2021: $122 · 2022: $487 · 2023: $4,321 · 2024: $43.63 · 2025: $27.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,540 · Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,539.84 |
| Food and Beverage | $352.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,159.33 | 2021-2024 | Davinci Xi, Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $610.02 | 2019-2022 | |
| Becton, Dickinson and Company | $102.37 | 2023 | Phasix Mesh |
| Baxter Healthcare | $92.57 | 2021 | |
| Atricure, INC. | $90.58 | 2023 | |
| Medtronic, INC. | $27.81 | 2025 | Transorb |
| Avanos Medical | $27.41 | 2019 | |
| Davol INC. | $23.43 | 2023 | Progel Applicator Spray Tips |
| Astrazeneca Pharmaceuticals Lp | $18.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcgrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.